| CPC A61K 49/0032 (2013.01) [A61B 5/201 (2013.01); A61K 49/0039 (2013.01); G01N 33/533 (2013.01); G01N 33/583 (2013.01); G01N 2800/347 (2013.01)] | 10 Claims |
|
1. A compound of formula I:
(X)a—Y—(Z)b I
where:
X is selected from:
![]() ![]() ![]() ![]() where R1 represents a biomarker reactive moiety conjugated to a self-immolative moiety
![]() wherein the self-immolative moiety is selected from:
![]() where the heteroatom directly bonded to the aromatic ring represents the point of attachment to Y and the other heteroatoms represent the point of attachment to a biomarker reactive moiety or are H, provided that at least one of the other heteroatoms is attached to a biomarker reactive moiety;
R2 represents a point of attachment to Y and R2′ represents another point of attachment to the same Y group or a point of attachment to a second Y group;
R3 represents H, SO3H or COOH;
Z is selected from:
![]() R4 is selected from:
![]() where the wavy line represents the point of attachment to the rest of the molecule;
R4′ represents the point of attachment to Y;
each Y is selected from:
![]() where the wavy line represents the point of attachment to X or Z,
![]() where the wavy line represents the point of attachment to X or Z,
![]() where each R5 is independently selected from H, CH2CHOHCH3, CH2CCH, and
![]() where the left-hand wavy line (adjacent to m) represents the point of attachment to X or Z and the right-hand wavy line represents the point of attachment to the rest of the molecule;
a is 0 or 1 and b is 1, provided that:
at least one of a and b is 1; and
when a and b are both 1, Y is selected from:
![]() or pharmaceutically acceptable salts and/or solvates thereof, provided that when X is
![]() then Z is 0.
|